The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex multi-step synthetic process. Preliminary routes focused on amino acid chain fragment coupling, utilizing https://theresapkjc442870.tblogz.com/creation-and-investigation-uses-of-retatrutide-53907469